Jianqing Lin
-
- Biochemical and Molecular Research 2
-
- SARS-CoV-2 and COVID-19 Research 2
- HIV/AIDS drug development and treatment 2
- Tuberculosis Research and Epidemiology 1
-
- Computational Drug Discovery Methods 2
-
- Peptidase Inhibition and Analysis 2
-
- Bacterial Genetics and Biotechnology 2
-
- Muscle and Compartmental Disorders 1
- Co-authors
- Liyan ZhuangMichael R. FreemanMichael L. LuKeith R. SolomonJulien LescarAbbas El SahiliBoon Chong GohSiu Kwan Sze
In The Last Decade
Jianqing Lin
12 papers receiving 330 citations
Peers
Comparison fields: 5 of 65
- Cancer Research 150
- Cell Biology 75
- Molecular Biology 175
- Immunology and Allergy 15
- Biochemistry 17
Countries citing papers authored by Jianqing Lin
This map shows the geographic impact of Jianqing Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianqing Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianqing Lin more than expected).
Fields of papers citing papers by Jianqing Lin
This network shows the impact of papers produced by Jianqing Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianqing Lin. The network helps show where Jianqing Lin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jianqing Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 2 | |
| 4 | 2023 | 6 | |
| 5 | 2023 | 4 | |
| 6 | 2022 | 3 | |
| 7 | 2021 | 5 | |
| 8 | 2020 | 9 | |
| 9 | 2020 | 6 | |
| 10 | 2019 | 10 | |
| 11 | 2018 | 10 | |
| 12 | [Role of 6% hydroxyethylstarch 130/0.4 and furosemide in the treatment of acute pancreatitis]. | 2010 | 2 |
| 13 | Cholesterol-rich lipid rafts mediate akt-regulated survival in prostate cancer cells. | 2002 | 274 |
About Jianqing Lin
Jianqing Lin is a scholar working on Infectious Diseases, Molecular Medicine and Endocrinology, having authored 13 papers that have together received 333 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (2 papers), Computational Drug Discovery Methods (2 papers), Biochemical and Molecular Research (2 papers), Peptidase Inhibition and Analysis (2 papers), Bacterial Genetics and Biotechnology (2 papers), HIV/AIDS drug development and treatment (2 papers), Muscle and Compartmental Disorders (1 paper) and Tuberculosis Research and Epidemiology (1 paper). The work is most often cited by research in Cancer Research (150 citations), Cell Biology (75 citations) and Molecular Biology (175 citations). Jianqing Lin has collaborated with scholars based in Singapore, China and Australia. Frequent co-authors include Liyan Zhuang, Michael R. Freeman, Michael L. Lu, Keith R. Solomon, Julien Lescar, Abbas El Sahili, Boon Chong Goh, Siu Kwan Sze, Nicolai Müller and Martin Savko. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.